Global Embolization Particle Market By Type (Microspheres, Particles (e.g. PVA Particles; Gelfoam Particles), Drug-eluting Beads (DEBs), and Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)), By Application (Uterine Fibroid Embolization, Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH), Liver Tumor Embolization, and Trauma Embolization), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029
- 136397
- 18-Dec
- PDF/PPT/Word
-
Report Details
The report on Embolization Particle Market offers in-depth analysis of market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report includes the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global embolization particle market is segmented on the basis of Type, Application, and geography.
The Worldwide market for Embolization Particle Market is expected to grow at a CAGR of roughly x.x% over the next nine years, and will reach US$ XX.X Mn in 2028, from US$ XX.X Mn in 2018, according to a new Market.us (Prudour Research) study.
Embolization Particle Market Scope:
By type, the market is segmented into Microspheres, Particles (e.g. PVA Particles; Gelfoam Particles), Drug-eluting Beads (DEBs), and Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere). By Application, the market is divided into Uterine Fibroid Embolization, Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH), Liver Tumor Embolization, and Trauma Embolization.
Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific Corporation, Terumo Corporation, Terumo Corporation, INterface BIOmaterials B.V., and Alicon.Key Market Segments
Type
Microspheres
Particles (e.g. PVA Particles; Gelfoam Particles)
Drug-eluting Beads (DEBs)
Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)Application
Uterine Fibroid Embolization
Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
Liver Tumor Embolization
Trauma EmbolizationKey Market Players included in the report:
Sirtex Medical
Merit Medical
Cook Medical
BTG Medical
Boston Scientific Corporation
Terumo Corporation
Terumo Corporation
INterface BIOmaterials B.V.
AliconReasons to Get this Report:
In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Embolization Particle Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Embolization Particle Market; high-growth regions; and market drivers, restraints, and also market chances.
The analysis covers Embolization Particle Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Embolization Particle Market across sections such as also Application and representatives.
Additionally, the analysis also has a comprehensive review of the crucial players on the Embolization Particle Market together side their company profiles, SWOT analysis, latest advancements, and business plans.The analysis objectives of the report are:
To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
To know the Embolization Particle Market by pinpointing its many subsegments.
To profile the important players and analyze their growth plans.
To endeavor the amount and value of Embolization Particle sub-markets, depending on key regions (various vital states).
To analyze Embolization Particle Market concerning growth trends, prospects, and also their participation in the entire sector.
To examine and study the Embolization Particle Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2014 to 2019, and also prediction to 2028.
Primary worldwide Embolization Particle Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market. -
Table Of Content
1. Embolization Particle Market Introduction
1.1. Definition
1.2. Taxonomy
1.3. Research Scope2. Executive Summary2.1. Key Findings by Major Segments
2.2. Top strategies by Major Players3. Global Embolization Particle Market Overview3.1. Embolization Particle Market Dynamics
3.1.1. Drivers
3.1.2. Opportunities
3.1.3. Restraints
3.1.4. Challenges 3.2. PESTLE Analysis
3.3. Opportunity Map Analysis
3.4. PORTER’S Five Forces Analysis
3.5. Market Competition Scenario Analysis
3.6. Product Life Cycle Analysis
3.7. Opportunity Orbits
3.8. Production Analysis by Region/Company
3.9. Industry chain Analysis
3.10. Marketing Strategy4. Global Embolization Particle Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-20284.1. Global Embolization Particle Market Analysis by Type: Introduction
4.2. Market Size and Forecast by Region
4.3. Microspheres4.4. Particles (e.g. PVA Particles; Gelfoam Particles)
4.5. Drug-eluting Beads (DEBs)
4.6. Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)5. Global Embolization Particle Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
5.1. Global Embolization Particle Market Analysis by Application: Introduction
5.2. Market Size and Forecast by Region
5.3. Uterine Fibroid Embolization5.4. Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
5.5. Liver Tumor Embolization
5.6. Trauma Embolization6. Global Embolization Particle Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
6.1. North America
6.1.1. North America Embolization Particle Market: Regional Trend Analysis
6.1.1.1. US
6.1.1.2. Canada
6.1.1.3. Mexico6.2.1. Europe
6.2.1. Europe Embolization Particle Market: Regional Trend Analysis
6.2.1.1. Germany
6.2.1.2. France
6.2.1.3. UK
6.2.1.4. Russia
6.2.1.5. Italy
6.2.1.6. Spain
6.2.1.7. Rest of Europe6.3. Asia-Pacific
6.3.1. Asia-Pacific Embolization Particle Market: Regional Trend Analysis
6.3.1.1. China
6.3.1.2. Japan
6.3.1.3. Korea
6.3.1.4. India
6.3.1.5. Rest of Asia-Pacific6.4. Latin America
6.4.1. Latin America Embolization Particle Market: Regional Trend Analysis
6.4.1.1. Brazil
6.4.1.2. Argentina
6.4.1.3. Rest of Latin America6.5. Middle East and Africa
6.5.1. Middle East and Africa Embolization Particle Market: Regional Trend Analysis
6.5.1.1. GCC
6.5.1.2. South Africa
6.5.1.3. Israel
6.5.1.4. Rest of MEA
7. Global Embolization Particle Market Competitive Landscape, Market Share Analysis, and Company Profiles7.1. Market Share Analysis
7.2. Company Profiles
7.3. Sirtex Medical7.3.1. Company Overview
7.3.2. Financial Highlights
7.3.3. Product Portfolio
7.3.4. SWOT Analysis
7.3.5. Key Strategies and Developments 7.4. Merit Medical7.4.1. Company Overview
7.4.2. Financial Highlights
7.4.3. Product Portfolio
7.4.4. SWOT Analysis
7.4.5. Key Strategies and Developments 7.5. Cook Medical7.5.1. Company Overview
7.5.2. Financial Highlights
7.5.3. Product Portfolio
7.5.4. SWOT Analysis
7.5.5. Key Strategies and Developments 7.6. BTG Medical7.6.1. Company Overview
7.6.2. Financial Highlights
7.6.3. Product Portfolio
7.6.4. SWOT Analysis
7.6.5. Key Strategies and Developments 7.7. Boston Scientific Corporation7.7.1. Company Overview
7.7.2. Financial Highlights
7.7.3. Product Portfolio
7.7.4. SWOT Analysis
7.7.5. Key Strategies and Developments 7.8. Terumo Corporation7.8.1. Company Overview
7.8.2. Financial Highlights
7.8.3. Product Portfolio
7.8.4. SWOT Analysis
7.8.5. Key Strategies and Developments 7.9. Terumo Corporation7.9.1. Company Overview
7.9.2. Financial Highlights
7.9.3. Product Portfolio
7.9.4. SWOT Analysis
7.9.5. Key Strategies and Developments 7.10. INterface BIOmaterials B.V.7.10.1. Company Overview
7.10.2. Financial Highlights
7.10.3. Product Portfolio
7.10.4. SWOT Analysis
7.10.5. Key Strategies and Developments 7.11. Alicon7.11.1. Company Overview
7.11.2. Financial Highlights
7.11.3. Product Portfolio
7.11.4. SWOT Analysis
7.11.5. Key Strategies and Developments8. Assumptions and Acronyms
9. Research Methodology
10. Contact -
Inquiry Before Buying
-
Request Sample